MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• EwertzMJensenABLate effects of breast cancer treatment and potentials for rehabilitationActa Oncol201150218719321231780
   PubMed Web of Science ®Google Scholar
• WeaverDLAshikagaTKragDNEffect of occult metastases on survival in node-negative breast cancerN Engl J Med2011364541242121247310
   PubMed Web of Science ®Google Scholar
• ShibataDMolecular tumor clocks to study the evolution of drug resistanceMol Pharm2011862050205421732670
   PubMedGoogle Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A200310073983398812629218
   PubMed Web of Science ®Google Scholar
• Velasco-VelázquezMAHomsiNDe La FuenteMPestellRGBreast cancer stem cellsInt J Biochem Cell Biol201244457357722249027
   PubMed Web of Science ®Google Scholar
• KimYJLiuYLiSCo-eradication of breast cancer cells and cancer stem cells by cross-linked multilamellar liposomes enhances tumor treatmentMol Pharm20151282811282226098197
   PubMed Web of Science ®Google Scholar
• DeanMFojoTBatesSTumour stem cells and drug resistanceNat Rev Cancer20055427528415803154
   PubMed Web of Science ®Google Scholar
• EaswaranHTsaiHCBaylinSBCancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistanceMol Cell201454571672724905005
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: target recognition and regulatory functionsCell2009136221523319167326
   PubMed Web of Science ®Google Scholar
• IorioMVCroceCMMicroRNA involvement in human cancerCarcinogenesis20123361126113322491715
   PubMed Web of Science ®Google Scholar
• LiuCTangDGMicroRNA regulation of cancer stem cellsCancer Res201171185950595421917736
   PubMed Web of Science ®Google Scholar
• BaoBAhmadAAzmiASAliSSarkarFHOverview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapyCurr Protoc Pharmacol2013 Chapter 14: Unit 14.25
   PubMedGoogle Scholar
• ShimonoYZabalaMChoRWDownregulation of miRNA-200c links breast cancer stem cells with normal stem cellsCell2009138359260319665978
   PubMed Web of Science ®Google Scholar
• CochraneDRSpoelstraNSHoweENNordeenSKRicherJKMicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule- targeting chemotherapeutic agentsMol Cancer Ther2009851055106619435871
   PubMed Web of Science ®Google Scholar
• CochraneDRHoweENSpoelstraNSLoss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancersJ Oncol2010201082171720049172
   PubMedGoogle Scholar
• WangHJiangYPengHChenYZhuPHuangYRecent progress in microRNA delivery for cancer therapy by non-viral synthetic vectorsAdv Drug Deliv Rev20158114216025450259
   PubMed Web of Science ®Google Scholar
• BravoVRoseroSRicordiCInstability of miRNA and cDNAs derivatives in RNA preparationsBiochem Biophys Res Commun200735341052105517204243
   PubMed Web of Science ®Google Scholar
• BaiMShenMTengYEnhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with UltrasoundOncotarget2015641437794379026575421
   PubMedGoogle Scholar
• YaoYSuZLiangYZhangNpH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-deliveryInt J Nanomedicine2015106185619726491291
   PubMed Web of Science ®Google Scholar
• YoonHYSonSLeeSJGlycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNASci Rep20144687825363213
   PubMed Web of Science ®Google Scholar
• Young YheeJSonSLeeHNanoparticle-based combination therapy for cancer treatmentCurr Pharm Des201521223158316626027570
   PubMed Web of Science ®Google Scholar
• YoonGParkJWYoonISSolid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug deliveryJ Pharm Invest2013435353362
   Google Scholar
• HeSNLiYLYanJJTernary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene deliveryInt J Nanomedicine201382859286923990715
   PubMed Web of Science ®Google Scholar
• HuFQZhangYDuYZYuanHNimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous systemInt J Pharm2008348114615217889464
   PubMedGoogle Scholar
• MorilleMPassiraniCVonarbourgAClavreulABenoitJPProgress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials200829243477349618499247
   PubMed Web of Science ®Google Scholar
• MuthiahMParkIKChoCSNanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeuticsExpert Opin Drug Deliv20131091259127323826971
   PubMed Web of Science ®Google Scholar
• HuFQJiangSPDuYZPreparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous systemColloids and Surf B: Biointerfaces200545316717316198092
   PubMed Web of Science ®Google Scholar
• DontuGAbdallahWMFoleyJMIn vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsGenes Dev200317101253127012756227
   PubMed Web of Science ®Google Scholar
• WahidFShehzadAKhanTKimYYMicroRNAs: synthesis, mechanism, function, and recent clinical trialsBiochim Biophys Acta20101803111231124320619301
   PubMed Web of Science ®Google Scholar
• TabattKSametiMOlbrichCMüllerRHLehrCMEffect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transferEur J Pharm Biopharm2003572155162
   Web of Science ®Google Scholar
• FriedrichJEderWCastanedaJA reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assayJ Biomol Screen200712792593717942785
   PubMedGoogle Scholar